Showing results (1-10 of 374) with videos related to
Sort By:
Pageof 38
Current Hematologic Malignancy Reports|August 10, 2016
Improving Prognostic Modeling in Myelodysplastic SyndromesAziz Nazha, Mikkael A SekeresAnnual Review of Medicine|September 14, 2016
Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential MutationsAziz Nazha, Mikkael A SekeresLeukemia & Lymphoma|March 30, 2017
Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failureSagar S Patel, Mikkael A Sekeres, Aziz NazhaThe Oncologist|July 22, 2015
Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Aziz Nazha, Mikkael A Sekeres, Steven D Gore, et al.Best Practice & Research. Clinical Haematology|November 24, 2018
The role of hypomethylating agents prior to hematopoietic cell transplantation in myelodysplastic syndromesMikkael A SekeresExpert Opinion on Biological Therapy|February 21, 2007
The myelodysplastic syndromesMikkael A SekeresCurrent Hematology Reports|December 22, 2004
Arsenic trioxide as a treatment for myelodysplastic syndromeMikkael A SekeresJournal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Non-transplant therapy for older adults with acute myeloid leukemiaMikkael A SekeresHematology. American Society of Hematology. Education Program|December 17, 2009
Treatment of MDS: something old, something new, something borrowedMikkael A SekeresLeukemia & Lymphoma|June 17, 2015
Managing patients with higher-risk myelodysplastic syndrome with stable disease on hypomethylating agentsMikkael A SekeresPageof 38